ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sobi buys rare-disease drug emapalumab, zooms in on hematology and immunology
June 14, 2019The drug-maker said that it would buy a newly established company owning the drug candidate for the treatment of primary haemophagocytic lymphohistiocytosis (HLH) -
US OKs first treatment for haemophagocytic lymphohistiocytos
November 22, 2018US regulators have approved Swedish Orphan Biovitrum (Sobi) and Novimmune’s Gamifant as the first treatment for the rare disorder primary haemophagocytic lymphohistiocytosis.
Pharma Sources Insight January 2025
